We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current TBIO market cap is 10.67M. The company's latest EPS is USD -1.6350 and P/E is -0.21.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.68M | 9.47M | 6.32M | 8.65M | 5.56M |
| Operating Income | -11.25M | -7.88M | -10.97M | -7.97M | -10.12M |
| Net Income | -12.31M | -8.13M | -11.12M | -8.44M | -11.2M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.81M | 6.58M | 11.04M | 27.44M | 27.51M |
| Operating Income | -6.98M | -16.36M | -35.37M | -46.49M | -46.54M |
| Net Income | -8.3M | -18.01M | -38.96M | -48.47M | -49.02M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 88.14M | 81.36M | 89.16M | 114.53M | 105.03M |
| Total Liabilities | 34.83M | 34.8M | 52.54M | 58.46M | 58.54M |
| Total Equity | 53.31M | 46.57M | 36.62M | 27.92M | 17.77M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 38.76M | 26.86M | 116.26M | 81.36M | 70.41M |
| Total Liabilities | 7.35M | 13.41M | 25.47M | 34.8M | 40.87M |
| Total Equity | -7.5M | -25.46M | 90.78M | 46.57M | 238k |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -33.08M | -38.72M | -11.17M | -21.47M | -27.36M |
| Investing | -29.22M | -18.01M | 4.12M | 10.97M | -12.24M |
| Financing | 4.4M | 4.51M | -18k | 26.69M | 26.59M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.39M | -15.38M | -36.7M | -38.72M | -34.67M |
| Investing | -79k | -204k | -15.04M | -18.01M | -5.74M |
| Financing | 35.11M | -96k | 121.08M | 4.51M | 11.57M |
| Market Cap | 10.67M |
| Price to Earnings Ratio | -0.21 |
| Price to Sales Ratio | 0.38 |
| Price to Cash Ratio | 6.68 |
| Price to Book Ratio | 0.36 |
| Dividend Yield | - |
| Shares Outstanding | 29.98M |
| Average Volume (1 week) | 72.75k |
| Average Volume (1 Month) | 66.83k |
| 52 Week Change | -86.27% |
| 52 Week High | 3.01 |
| 52 Week Low | 0.2997 |
| Spread (Intraday) | 0.04 (12.26%) |
| Company Name | Telesis Bio Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.codexdna.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
